You are here

GSK

Haleon releases first earnings since GSK spin off, rebuffs Zantac claims

Medical Marketing and Media

Tue, 09/20/22 - 08:35 pm

consumer health

Theravance declares independence from GSK, crafts $250M plan to buy back its own shares

Endpoints

Mon, 09/19/22 - 09:09 am

A month after GSK's win in Zantac cancer case, plaintiffs file dozens more suits

Endpoints

Sun, 09/18/22 - 10:21 pm

Sanofi, AZ's blockbuster hopeful RSV med nears first approval as showdown with Pfizer, GSK looms

Fierce Pharma

Fri, 09/16/22 - 10:54 am

GSK’s Zejula offers lasting PFS benefit in Phase III ovarian cancer trial

Clinical Trials Arena

Mon, 09/12/22 - 11:34 pm

clinical trials

ESMO 2022 – Springworks aims to Defi expectations

EP Vantage

Mon, 09/12/22 - 10:31 am

ESMO: GSK keeps the faith in anti-TIGIT plans; it's 'not always about being first'

Fierce Biotech

Fri, 09/9/22 - 12:08 pm

Teva fires back at GSK again over potential 'skinny' label SCOTUS case

Endpoints

Thu, 09/8/22 - 04:43 pm

Teva Pharmaceutical

GSK taps Medable for decentralized clinical trials, patient diversity

Fierce Biotech

Thu, 09/8/22 - 10:40 am

clinical trials

decentralized clinical trials

AstraZeneca scores injunction to temporarily halt former exec's start at crosstown rival GSK

Fierce Pharma

Wed, 08/31/22 - 10:39 pm

Revealed: which pharma companies leading the way in artificial intelligence

Clinical Trials Arena

Fri, 08/26/22 - 10:37 am

artificial intelligence

Johnson & Johnson

Bristol Myers Squibb

GSK claps back at Teva in 'skinny' label case, arguing verdict doesn't threaten companies who act 'properly'

Fierce Pharma

Tue, 08/23/22 - 10:29 am

Teva Pharmaceutical

In damage control mode, Perrigo clarifies that it's off the hook in key Zantac case

Fierce Pharma

Thu, 08/18/22 - 11:18 pm

Boehringer Ingelheim

GSK clinches $170M malaria vaccine supply deal after 3 decades of research

Fierce Pharma

Wed, 08/17/22 - 11:03 am

AstraZeneca heads to court to contest former exec's move to crosstown rival GSK: report

Fierce Pharma

Tue, 08/16/22 - 10:54 am

GSK turns down one solid tumor collaboration, but Ideaya thinks it’s for the best

Fierce Biotech

Mon, 08/15/22 - 10:26 am

precision medicine

GSK bets $1.3B on Mersana’s preclinical ADC and chance to expand portfolio beyond Blenrep

Fierce Biotech

Mon, 08/8/22 - 11:45 pm

antibody-drug conjugate

GSK and IQVIA launch Vaccine Track, a data trend platform to help improve adult vaccination in communities nationwide

Businesswire

Mon, 08/8/22 - 11:35 pm

adult vaccinations

GSK ups sales guidance on back of Shingrix strength

Biopharma Reporter

Mon, 08/1/22 - 10:43 am

consumer health

Hepatitis B: can GSK’s bepirovirsen deliver functional cure?

Clinical Trials Arena

Fri, 07/29/22 - 10:10 am

Pages